The development of personalised medicine was discussed in the Research and Development Council

17.12.2013 | 17:39

News
    • Share
Tallinn, Stenbock House, 17 December 2013 – the Research and Development Council, which gathered today in Stenbock House, advised the Minister of Social Affairs to analyse options for national implementation of personalised medicine in co-operation with the Estonian Academy of Sciences and continue discussions on this topic during the development of the research and development strategy in the health sector. The analysis of the Estonian Development Fund shows that there is a consensus in Estonia on the need for patient-centred or personalised medicine. Personalised medicine means health care services in the case of which all of a person’s available health records will be systematically used to ensure that the decisions and recommendations are based on a complete understanding of how a specific person’s health is dependent on the links between his or her genes, behaviour, and the external environment. The broader application of personalised medicine would provide opportunities to enhance preventive health behaviour and make better decisions in treating people. The systematic use of different individual data on a person’s health when making decisions is possible only with the support of very good e-health applications.The Research and Development Council also approved the draft act of the Tallinn University of Technology, laying down the specifications for the university’s actions compared to other public universities functioning in Estonia. At the meeting, researchers from the Estonian University of Life Sciences introduced the transgenic (TG) technology development experience and opportunities in Estonia. TG technology refers to genetic modification in the manner in which the gene transferred into the body will provide the body with a new feature, which is also inherited by the progeny. It was noted that the TG technology has great potential in both medicine and agriculture. For example, it enables one to produce pharmaceuticals from the TG animal’s milk, as well as tissues and organs for transplantation purposes. In agriculture, it provides an opportunity to improve the quality of milk and meat and to increase resistance to diseases. Additionally, the Minister of Education and Research gave an overview on the implementation of the strategy “Knowledge-based Estonia” in 2013 at today’s meeting of the Research and Development Council. The Research and Development Council advises the Government in matters related to the research and development strategy. The Chairman of the Research and Development Council is the Prime Minister.

Valitsuse kommunikatsioonibüroo

-